• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC REFOBACIN BONE CEMENT R; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Information (3190)
Event Date 11/11/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(6).(b)(4).The product within this report is a combination product.Reserve sample was evaluated and the reported event was not confirmed.No unusual behavior during mixing, handling or setting was observed under standard conditions.Device history record (dhr) was reviewed and no discrepancies were found.The complaint was not confirmed and therefore root cause of the reported event cannot be determined; however, the behavior of cement is dependent on both storage and surgical theatre temperature.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported the customer is experiencing big variations in handling time of the bone cement.No further information is available at this time.
 
Manufacturer Narrative
A retained sample from the batch was evaluated and the reported event was unable to be confirmed.No unusual behavior during mixing, handling or setting was detected.Dhr was reviewed and no discrepancies were found.The complaint was not confirmed as the retained sample analysis indicated that the batch met specification.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.Retained sample of batch evaluated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC REFOBACIN BONE CEMENT R
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key7142641
MDR Text Key95794301
Report Number3006946279-2017-00293
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeNO
PMA/PMN Number
PK150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date05/31/2018
Device Model NumberN/A
Device Catalogue Number4711500396-1
Device Lot NumberA647C05635
Other Device ID NumberSEE H10 NARRATIVE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/27/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured12/22/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
-
-